Dexcom Inc
DXCM75.580USD
-0.640-0.84%
Handelsschluss 09/15, 16:00（ET）Kurse um 15 Minuten verzögert
29.64BMarktkapitalisierung
51.87KGV TTM
mehr Informationen über Dexcom Inc Unternehmen
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Unternehmensinformationen
BörsenkürzelDXCM
Name des UnternehmensDexcom Inc
IPO-datumApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Anzahl der mitarbeiter10300
WertpapierartOrdinary Share
GeschäftsjahresendeApr 14
Addresse6340 Sequence Dr
StadtSAN DIEGO
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl92121
Telefon18582000200
Websitehttps://www.dexcom.com/
BörsenkürzelDXCM
IPO-datumApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.26K
+6.52%
Mr. Kevin R. Sayer
Mr. Kevin R. Sayer
Executive Chairman of the Board
Executive Chairman of the Board
233.94K
+11.70%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Lead Independent Director
Lead Independent Director
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.33K
-12.01%
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Independent Director
Independent Director
28.04K
+21.94%
Mr. Kyle Malady
Mr. Kyle Malady
Independent Director
Independent Director
22.67K
-2.86%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Independent Director
Independent Director
9.04K
+127.87%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.26K
+6.52%
Mr. Kevin R. Sayer
Mr. Kevin R. Sayer
Executive Chairman of the Board
Executive Chairman of the Board
233.94K
+11.70%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Lead Independent Director
Lead Independent Director
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Distributor
880.00M
84.94%
Direct
156.00M
15.06%
Nach RegionUSD
Name
Umsatz
Anteil
United States
750.50M
72.44%
Outside of United states
285.50M
27.56%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Distributor
880.00M
84.94%
Direct
156.00M
15.06%
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Global Advisors (US)
4.30%
Baillie Gifford & Co.
4.26%
Jennison Associates LLC
2.94%
Andere
70.04%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Global Advisors (US)
4.30%
Baillie Gifford & Co.
4.26%
Jennison Associates LLC
2.94%
Andere
70.04%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.41%
Investment Advisor/Hedge Fund
29.00%
Research Firm
3.41%
Hedge Fund
3.01%
Pension Fund
2.04%
Bank and Trust
1.84%
Sovereign Wealth Fund
1.51%
Venture Capital
0.40%
Individual Investor
0.37%
Andere
2.01%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
2212
390.97M
99.70%
-27.53M
2025Q1
2252
386.55M
98.59%
-25.17M
2024Q4
2220
380.88M
97.47%
-26.96M
2024Q3
2145
382.31M
97.83%
-30.58M
2024Q2
2115
397.02M
99.11%
-4.31M
2024Q1
2093
389.18M
98.33%
-19.87M
2023Q4
2081
398.01M
103.26%
+83.33K
2023Q3
1994
389.89M
100.89%
-11.88M
2023Q2
1952
389.17M
100.78%
-12.73M
2023Q1
1908
390.83M
100.84%
-11.09M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
47.29M
12.06%
+929.54K
+2.01%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
24.72M
6.3%
+538.41K
+2.23%
Mar 31, 2025
State Street Global Advisors (US)
16.68M
4.25%
-3.42K
-0.02%
Mar 31, 2025
Baillie Gifford & Co.
14.18M
3.62%
-432.96K
-2.96%
Mar 31, 2025
Jennison Associates LLC
10.52M
2.68%
+2.88M
+37.67%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.41M
2.65%
+414.04K
+4.14%
Mar 31, 2025
Sands Capital Management, LLC
10.41M
2.66%
-695.35K
-6.26%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
8.10M
2.07%
-3.50K
-0.04%
Jun 30, 2025
Nuveen LLC
7.85M
2%
+21.73K
+0.28%
Mar 31, 2025
MFS Investment Management
3.19M
0.81%
+2.01M
+170.89%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Global X Internet of Things ETF
5.84%
Langar Global HealthTech ETF
5.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
5.19%
Fidelity Digital Health ETF
4.16%
Harbor Health Care ETF
4.09%
Global X HealthTech ETF
3.89%
iShares U.S. Medical Devices ETF
3.47%
Touchstone Sands Capital US Select Growth ETF
3.06%
Goldman Sachs Future Health Care Equity ETF
2.82%
Global X Aging Population ETF
2.5%
Mehr Anzeigen
Global X Internet of Things ETF
Anteil5.84%
Langar Global HealthTech ETF
Anteil5.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil5.19%
Fidelity Digital Health ETF
Anteil4.16%
Harbor Health Care ETF
Anteil4.09%
Global X HealthTech ETF
Anteil3.89%
iShares U.S. Medical Devices ETF
Anteil3.47%
Touchstone Sands Capital US Select Growth ETF
Anteil3.06%
Goldman Sachs Future Health Care Equity ETF
Anteil2.82%
Global X Aging Population ETF
Anteil2.5%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Mar 28, 2022
Split
1→4
Datum
Art
Verhältnis
Mar 28, 2022
Split
1→4
